Policy & Medicine - Legal, Regulatory, and Compliance Issues

The first U.S. biosimilar is one step closer to entering the marketplace. Last week, U.S. District Judge Richard Seeborg…

Life sciences companies are an “increasingly popular target of securities fraud class action lawsuits,” a recent survey…

Tomorrow, March 24, Arnold and Porter will be hosting a webcast entitled "Beyond Product Launch: Navigating FDA Post-Market…

Last week, Newsweek published an article entitled “The Ugly Civil War in American Medicine,” in which the author derided the…

On March 11, the Oregon House of Representatives introduced House Bill 3486, which would require pharmaceutical…

In August of 2012, Johnson & Johnson paid a $181 million multi-state consumer protection settlement to resolve…

The HHS Office of Inspector General (OIG) yesterday announced that Sandoz Inc. will pay $12.64 million to settle allegations it…

Last year saw the release of two large physician databases—Open Payments and the “Medicare Provider Utilization and…

The ninth International Pharmaceutical Compliance Congress and Best Practices Forum is returning to Brussels, where the first was…

HHS-OIG recently released their 2015 Health Reform Oversight Plan. The agency plans to hone in on the Affordable Care Act during…